ATHE fundamentals
Alterity Therapeutics Limited earnings per share and revenue
Estimated earnings per share for the next semiannual are -0.53 USD, and revenue is expected to reach 2.30 M USD. Also watch annual changes over time to get a bigger picture of ATHE earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise